Skip to content
OpenCapital
Get started

Corteva CTVA Biologicals — Net Sales

Other product segments

Herbicides
$813M+10.5%
Corn
$586M+86.0%
Insecticides
$409M-6.4%
Fungicides
$222M+2.8%
Soybean
$152M-7.3%
Other
$148M-21.3%
Other oilseeds
$141M+4.4%

Similar metrics at other companies

AVT
AVTRBioscience & Medtech Products — Net Sales
$431.4M+1.2%
Materion logo
MTRNLife sciences — Net Sales
-$1.53M-113%
Rayonier Advanced Materials logo
RYAMBiomaterials and other — Net Sales
$12.62M+12.2%
International Flavors & Fragrances logo
IFFHealth & Biosciences — Net Sales
$595M+10.2%
GLW
GLWLife Science Products — Net Sales
$228M0.0%
Bio-Rad Laboratories logo
BIOLife Science — Net Sales
$228.5M0.0%

Other financials

Income statement

See full
Revenue$2.6B+12.6%
Gross profit$974.0M+28.0%
Net income-$320.0M+38.9%
EPS (diluted)-$0.47+38.2%

Balance sheet

See full
Cash & equivalents$2.5B+3.6%
Total debt$788.0M+57.3%
Total equity$25.2B+1.9%
Total assets$42.2B+0.7%

Cash flow

See full
Operating cash flow-$2.1B+19.2%
CapEx$157.0M+1.9%
Free cash flow-$2.2B+20.1%

Valuation

See full
Market cap$54.59B+8.5%
Enterprise value$52.87B+8.0%
P/E33.2×-9.4×
P/S3.1×+0.1×

Profitability

See full
Gross margin46.1%+2.6pp
Net margin9.4%—
FCF margin12.5%+1.3pp

Returns & leverage

See full
Return on equity6.6%—
Debt / equity0×0.0×
Current ratio1.6×+0.1×

Where this comes from

Reported directly by Corteva in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Corteva’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Corteva's biologicals — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Corteva's biologicals — net sales?
Corteva (CTVA) reported biologicals — net sales of $147M in Q3 2025.
How has Corteva's biologicals — net sales changed year-over-year?
Corteva's biologicals — net sales increased by 8.9% year-over-year, from $135M to $147M.
What is the long-term trend for Corteva's biologicals — net sales?
Over 2 years (2022 to 2024), Corteva's biologicals — net sales has grown at a 174.9% compound annual growth rate (CAGR), from $63M to $476M.
What does biologicals — net sales mean?
This metric represents the total revenue generated from the sale of biological agricultural products, including biostimulants, biocontrols, and pheromones. These products are designed to enhance crop health, improve nutrient efficiency, and provide sustainable pest management solutions as an alternative or supplement to traditional synthetic chemicals. Growth in this segment reflects the company's strategic pivot toward sustainable and high-margin agricultural technologies.